Teloxantrone

Drug Profile

Teloxantrone

Alternative Names: CI 937; DUP 937; Moxantrazole; NSC 355644; PD 113309

Latest Information Update: 24 Sep 2002

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Pfizer
  • Class Cytostatics
  • Mechanism of Action DNA inhibitors; Type II DNA topoisomerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cancer

Most Recent Events

  • 24 Sep 2002 Discontinued - Phase-I for Cancer in Canada (unspecified route)
  • 24 Sep 2002 Discontinued - Phase-I for Cancer in USA (unspecified route)
  • 12 Jul 2000 Profile reviewed but no significant changes made
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top